Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: BDSX

Biodesix, Inc.

Healthcare | Medical - Diagnostics & Research

No licensed closing price on file for BDSX. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

Biodesix, Inc. (NASDAQ: BDSX) is a diagnostics and research company. Figures from SEC EDGAR; updated 2026-10-20 16:51 UTC.

What Biodesix, Inc. does

Biodesix is a diagnostic solutions company that generates revenue from two main sources: lung diagnostic testing services using blood-based tests, and development services providing diagnostic testing and consulting to biopharmaceutical and life sciences companies. The company offers tests that assess cancer risk in lung nodules and provide treatment guidance after lung cancer diagnosis, addressing clinical needs across the lung cancer care continuum.

Summarized from Biodesix, Inc.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Valuation
Return on equity1,430.63%
Debt/equity5.47

Revenue, margins & earnings

FY2021: net loss $43M on revenue $55M$55MFY2021FY2022: net loss $65M on revenue $38M$38MFY2022FY2023: net loss $52M on revenue $49M$49MFY2023FY2024: net loss $43M on revenue $71M$71MFY2024FY2025: net loss $35M on revenue $88M$88MFY2025
  • Net income
  • Taxes & interest
  • Operating costs
  • Net loss year
Annual revenue; bands show net, operating margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-10-02
  • 2026-10-02DirectorRestricted Stock UnitsOption exercise-1,360—
  • 2026-10-02DirectorOption exercise1,360—
  • 2026-08-1310% OwnerPurchase15,000$367.0K
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Biodesix, Inc. do?

Biodesix is a diagnostic solutions company that generates revenue from two main sources: lung diagnostic testing services using blood-based tests, and development services providing diagnostic testing and consulting to biopharmaceutical and life sciences companies.

When did BDSX last file with the SEC?

Biodesix, Inc.'s most recent SEC filing on record is a 8-K filed 2026-05-20. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 16:51 UTC. This page is also available as JSON at /api/data?ticker=BDSX and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for BDSX and 5,000+ tickers.

Create a free account — keep BDSX
For your agent
GET /api/data?ticker=BDSX

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt